Markets:

Overview

News

Currencies

International

Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

38.22 -2.25 (-5.56%)

Streaming Delayed Price Updated: 3:46 PM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Corcept Therapeutics Incorporated - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

18 19 Next >

Here's How Much $1000 Invested In Corcept Therapeutics 5 Years Ago Would Be Worth Today ↗

May 30, 2025

Via Benzinga

1 Growth Stock with All-Star Potential and 2 to Avoid

May 26, 2025

Growth is oxygen. But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID...

Via StockStory

Topics Artificial Intelligence

CORCEPT THERAPEUTICS INC (NASDAQ:CORT) – A Strong Growth Stock with Technical Breakout Potential ↗

May 22, 2025

CORCEPT THERAPEUTICS (NASDAQ:CORT) shows strong growth fundamentals and a bullish technical setup, making it a stock to watch. High revenue growth, profitability, and a debt-free balance sheet support...

Via Chartmill

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)

May 21, 2025

Let’s dig into the relative performance of Corcept (NASDAQ:CORT) and its peers as we unravel the now-completed Q1 branded pharmaceuticals earnings season.

Via StockStory

Topics Artificial Intelligence Intellectual Property

Earnings Scheduled For May 5, 2025 ↗

May 05, 2025

Via Benzinga

CORT Q1 Earnings Call: Pharmacy Disruptions Overshadow Prescription Growth, Guidance Reaffirmed

May 19, 2025

Biopharma company Corcept Therapeutics (NASDAQ:CORT) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 7.1% year on year to $157.2 million. On the other hand, the company’s...

Via StockStory

Here's How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 5 Years ↗

May 12, 2025

Via Benzinga

Looking for growth without the hefty price tag? Consider CORCEPT THERAPEUTICS INC (NASDAQ:CORT). ↗

May 10, 2025

Uncover the potential of CORCEPT THERAPEUTICS INC, a growth stock reasonably priced. NASDAQ:CORT is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive...

Via Chartmill

How Do Investors Really Feel About Corcept Therapeutics? ↗

May 09, 2025

Via Benzinga

Will CORCEPT THERAPEUTICS INC (NASDAQ:CORT) breakout? ↗

May 08, 2025

Exploring CORCEPT THERAPEUTICS INC's Technical Signals and Breakout Potential: Indications Suggest NASDAQ:CORT Could Be on the Verge of a Breakout.

Via Chartmill

1 Small-Cap Stock Worth Your Attention and 2 to Question

May 08, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Assessing Corcept Therapeutics: Insights From 9 Financial Analysts ↗

May 06, 2025

Via Benzinga

Corcept Therapeutics Stock Jumps On Record Prescription Volume: Retail Sentiment Soars ↗

May 05, 2025

The pharma company saw a surge in retail sentiment following its Q1 update, which reaffirmed its 2025 revenue guidance of $900 million to $950 million.

Via Stocktwits

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 05, 2025

Via Benzinga

Corcept (NASDAQ:CORT) Misses Q1 Sales Targets, Stock Drops

May 05, 2025

Biopharma company Corcept Therapeutics (NASDAQ:CORT) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 7.1% year on year to $157.2 million. On the other hand, the company’s...

Via StockStory

Topics Artificial Intelligence

Top movers in Monday's after hours session ↗

May 05, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 05, 2025

From Corcept Therapeutics

Via Business Wire

Corcept (CORT) To Report Earnings Tomorrow: Here Is What To Expect

May 04, 2025

Biopharma company Corcept Therapeutics (NASDAQ:CORT) will be reporting earnings tomorrow after the bell. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

CORCEPT THERAPEUTICS INC (NASDAQ:CORT), a strong growth stock, setting up for a breakout. ↗

April 30, 2025

Based on a technical and fundamental analysis of NASDAQ:CORT we ask: Is CORCEPT THERAPEUTICS INC (NASDAQ:CORT) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL

April 28, 2025

From Corcept Therapeutics Incorporated

Via Business Wire

3 Healthcare Stocks That Concern Us

April 28, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

Here's How Much $1000 Invested In Corcept Therapeutics 10 Years Ago Would Be Worth Today ↗

April 25, 2025

Via Benzinga

CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025

April 23, 2025

From Corcept Therapeutics Incorporated

Via Business Wire

Diabetes Care Publishes Results From Prevalence Phase Of Corcept’s CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes

April 21, 2025

From Corcept Therapeutics Incorporated

Via Business Wire

SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know

April 16, 2025

A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that...

Via StockStory

Topics Artificial Intelligence Economy Government

$1000 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth This Much Today ↗

April 16, 2025

Via Benzinga

Investors seeking growth at a reasonable cost should explore CORCEPT THERAPEUTICS INC (NASDAQ:CORT). ↗

April 15, 2025

NASDAQ:CORT is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.

Via Chartmill

3 Biopharmaceutical Stocks Bucking the Sell-Off

April 10, 2025

Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.

Via MarketBeat

Topics World Trade

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

April 10, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Eli Lilly (NYSE:LLY) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

April 08, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst...

Via StockStory

Topics Artificial Intelligence Intellectual Property

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.